CHICAGO, July 31, 2012 /PRNewswire/ --Zacks Equity Research highlights Ferrellgas Partners L.P. (NYSE:FGP) as the Bull of the Day and GlaxoSmithKline, plc (NYSE:GSK) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onEquinix Inc. (Nasdaq:EQIX), AT&T Inc. (NYSE:T) and Verizon Inc. (NYSE:VZ).
(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)
Full analysis of all these stocks is available at http://at.zacks.com/?id=2678.
Here is a synopsis of all five stocks:
Bull of the Day:
We have upgraded our recommendation on Ferrellgas Partners L.P. (NYSE:FGP) to Outperform from Neutral, taking into consideration its strong acquisition strategy, lower cost of operation, debt minimization efforts and financial flexibility. The partnership has also increased its unitholder value through payment of cash distribution.
In addition, a warmer-than-expected summer is likely to improve the partnership's sales volume, though we are skeptical about the seasonal variance in the demand for propane and a highly competitive propane distribution business environment. Over the long run, however, we expect the partnership to outperform its peers given its focus on unitholders and cost minimization efforts.
The trailing 12-month EV/EBITDA multiple of the partnership is 18.4x, which is higher than the industry average of 5.8x. Our $24 target price reflects a P/CF multiple of 25.36 based on 2012 EPU (earnings per unit).
Bear of the Day:
GlaxoSmithKline, plc's (NYSE:GSK) second quarter earnings of $0.79 per ADS were below the Zacks Consensus Estimate of $0.84. Earnings fell 2.5% year over year. Revenues fell 7.3% y/y to $10.2 billion, missing the Zacks Consensus Estimate of $10.4 billion.
Glaxo expects 2012 revenues to remain flat y/y (at CER). Earlier, Glaxo was expecting revenues to grow from 2011 levels. Guidance was lowered due to EU pricing pressure. A major part of Glaxo's revenues will be exposed to generic competition as multiple drugs are scheduled to lose exclusivity in the next few years. We expect the company's top line as well as gross margins to remain under pressure in the coming quarters.
In addition to generic competition, US health care reform and EU pricing pressure will continue to affect sales. Thus, we maintain our Underperform recommendation on Glaxo, which carries a Zacks #4 Rank (short-term Sell rating).
Latest Posts on the Zacks Analyst Blog:
Equinix Expands Brazil Footprint
Leading data center solutions provider Equinix Inc. (Nasdaq:EQIX) announced its intention to set up a new International Business Exchange data center (RJ2) in Rio de Janeiro, Brazil. The estimated cost would be roughly $20.0 million for the first phase of the facility.
The first phase is expected to be completed by 2013, after which the facility will accommodate 320 cabinets. The subsequent phases will allow the setting up of 850 additional cabinets.
The RJ2 data center will be developed under the supervision of ALOG Data Centers of Brazil, S.A. Equinix took over a 90.0% stake in ALOG in April 2011 for $127.0 million. The purpose of the acquisition was to enable Equinix to grab a bigger share of the growing data center market in Brazil and Lain America.
Apart from the new data center, Equinix also announced plans to proceed with the second phase of another data center (SP2) in Sao Paulo. Development costs are estimated to be $14.0 million, with the extension expected to be operational by the beginning of 2013. The facility will host 350 cabinets.
Equinix's data center platform has been popular in the financial services, networking and content management industries. Equinix has taken advantage of the fact that many firms in these industries are setting up their bases in South America. Seeing the growth prospects in the region, particularly in Brazil, we believe Equinix will be able to meet the growing demand and secure a solid revenue stream.
Equinix boasts a presence across various geographical regions and is increasingly becoming popular among major players in the tech industry for data management. The company's worldwide presence has resulted in high network density with a vertically focused approach, which will continue to support demand.
The company has delivered decent second quarter 2012 results with EPS exceeding the company's expectation. Moreover, revenue improved substantially on a year-over-year basis on improved colocation, interconnection and managed infrastructure services. Guidance for the third quarter and fiscal 2012 was encouraging.
However, a heightened debt situation, competitive threats from the likes of AT&T Inc. (NYSE:T) and Verizon Inc. (NYSE:VZ) and European exposure keeps us on the sidelines.
Equinix carries a Zacks #3 Rank, implying a short-term Hold rating.
Get the full analysis of all these stocks by going to http://at.zacks.com/?id=2649.
About the Bull and Bear of the Day
Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.
About the Analyst Blog
Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=7158.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4582.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
SOURCE Zacks Investment Research, Inc.
